thalidomide has been researched along with Facial Dermatoses in 17 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with sarcoidosis was treated with thalidomide for disfiguring and painful steroid unresponsive sarcoidal granulomas of the skin." | 7.70 | Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report. ( Koblenzer, PS; Lee, JB, 1998) |
| "Thalidomide has a different toxicity profile than corticosteroids or immunosuppressives." | 6.42 | Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. ( Baughman, RP; Lower, EE, 2004) |
| "Actinic prurigo is an uncommon and usually persistent idiopathic photodermatosis with typical human leukocyte antigen (HLA) associations (HLA-DR4, particularly subtypes DRB1*0407 and DRB1*0401)." | 6.41 | A case of severe actinic prurigo successfully treated with thalidomide. ( Baker, CS; Crouch, RB; Foley, PA; Ng, JC, 2001) |
| "A patient with sarcoidosis was treated with thalidomide for disfiguring and painful steroid unresponsive sarcoidal granulomas of the skin." | 3.70 | Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report. ( Koblenzer, PS; Lee, JB, 1998) |
| "Thalidomide has a different toxicity profile than corticosteroids or immunosuppressives." | 2.42 | Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. ( Baughman, RP; Lower, EE, 2004) |
| "Actinic prurigo is an uncommon and usually persistent idiopathic photodermatosis with typical human leukocyte antigen (HLA) associations (HLA-DR4, particularly subtypes DRB1*0407 and DRB1*0401)." | 2.41 | A case of severe actinic prurigo successfully treated with thalidomide. ( Baker, CS; Crouch, RB; Foley, PA; Ng, JC, 2001) |
| "We report a case of xanthoma disseminatum (XD) in which localized skin and mucous impairment revealed multisystem involvement." | 1.42 | [Xanthoma disseminatum with asymptomatic multisystem involvement]. ( Benchikhi, H; Hali, F; Lazaar, S; Marnissi, F; Zinoun, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Kaushik, A | 1 |
| Kumaran, MS | 1 |
| Chatterjee, D | 1 |
| De, D | 1 |
| Loyal, J | 1 |
| Flores, S | 1 |
| Alikhan, A | 1 |
| Di Cesare, A | 1 |
| Pescitelli, L | 1 |
| Ricceri, F | 1 |
| Lazzeri, L | 1 |
| Prignano, F | 1 |
| Georgakopoulou, EA | 1 |
| Scully, C | 1 |
| Wang, F | 1 |
| Zhou, H | 1 |
| Luo, DQ | 1 |
| Han, JD | 1 |
| Chen, MK | 1 |
| Zinoun, M | 1 |
| Hali, F | 1 |
| Marnissi, F | 1 |
| Lazaar, S | 1 |
| Benchikhi, H | 2 |
| Wruhs, M | 1 |
| Loader, D | 1 |
| Breier, F | 1 |
| Feldmann, R | 1 |
| Rehberger, A | 1 |
| Steiner, A | 1 |
| Tjiu, JW | 1 |
| Hsiao, CH | 1 |
| Tsai, TF | 1 |
| Deng, YJ | 1 |
| Hao, F | 1 |
| Zhou, CL | 1 |
| Sun, RS | 1 |
| Xiang, MM | 1 |
| Wang, JW | 1 |
| Zhong, BY | 1 |
| Ye, QY | 1 |
| Liu, RQ | 1 |
| Caradonna, S | 1 |
| Jacobe, H | 1 |
| Baughman, RP | 1 |
| Lower, EE | 1 |
| Kawakami, T | 1 |
| Tsutsumi, Y | 1 |
| Mizoguchi, M | 1 |
| Ishi, N | 1 |
| Soma, Y | 1 |
| Lee, JB | 1 |
| Koblenzer, PS | 1 |
| Bodemer, C | 1 |
| Fraitag, S | 1 |
| Wechsler, J | 1 |
| Delfau-Larue, MH | 1 |
| Gounod, N | 1 |
| de Prost, Y | 1 |
| Revuz, J | 1 |
| Bagot, M | 1 |
| Moraes, M | 1 |
| Russo, G | 1 |
| Ng, JC | 1 |
| Foley, PA | 1 |
| Crouch, RB | 1 |
| Baker, CS | 1 |
| Picard, C | 1 |
| Crickx, B | 1 |
| Perron, J | 1 |
| Lecerf, V | 1 |
| Belaïch, S | 1 |
6 reviews available for thalidomide and Facial Dermatoses
| Article | Year |
|---|---|
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; | 2015 |
Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
Topics: Facial Dermatoses; Female; Histiocytosis, Sinus; Humans; Immunosuppressive Agents; Middle Aged; Thal | 2003 |
Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents.
Topics: Chronic Disease; Clinical Trials as Topic; Facial Dermatoses; Humans; Immunosuppressive Agents; Sarc | 2004 |
Thalidomide and its dermatologic uses.
Topics: Acquired Immunodeficiency Syndrome; Behcet Syndrome; Dermatologic Agents; Erythema Nodosum; Facial D | 2001 |
A case of severe actinic prurigo successfully treated with thalidomide.
Topics: Adult; Arm; Dermatitis, Photoallergic; Dermatologic Agents; Diagnosis, Differential; Facial Dermatos | 2001 |
[Florid cutaneous sarcoidosis. Therapeutic difficulties].
Topics: Adrenal Cortex Hormones; Cyclosporins; Facial Dermatoses; Humans; Male; Middle Aged; PUVA Therapy; S | 1989 |
11 other studies available for thalidomide and Facial Dermatoses
| Article | Year |
|---|---|
The Search for a Uniformly Effective Treatment in Patients With Lupus Miliaris Disseminatus Faciei.
Topics: Administration, Oral; Adult; Facial Dermatoses; Granuloma; Humans; Male; Phosphodiesterase 4 Inhibit | 2020 |
Resolution of psoriasis after tonsillectomy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Facial Dermatoses; Female; Glucocorticoids; Humans; Pharyng | 2017 |
Cutaneous hyperpigmentation induced by apremilast.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Facial Dermatoses; Female; Foll | 2018 |
Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
Topics: Adult; Dermoscopy; Diagnosis, Differential; Dose-Response Relationship, Drug; Facial Dermatoses; Fem | 2014 |
[Xanthoma disseminatum with asymptomatic multisystem involvement].
Topics: Adrenal Cortex Hormones; Adult; Antigens, CD; Bone and Bones; Diagnosis, Differential; Facial Dermat | 2015 |
Extensive purpuric lesions on the face.
Topics: Aged, 80 and over; Amyloidosis; Diagnosis, Differential; Face; Facial Dermatoses; Female; Humans; Im | 2015 |
Generalized eruptive histiocytosis: a possible therapeutic cure?
Topics: Adult; Dermatologic Agents; Drug Therapy, Combination; Facial Dermatoses; Histiocytosis, Langerhans- | 2004 |
Thalidomide as a potential treatment for scleromyxedema.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Immunosuppr | 2004 |
Clinicopathologic challenge.
Topics: Adult; Diagnosis, Differential; Erythema Nodosum; Extremities; Facial Dermatoses; Female; Humans; Le | 2007 |
Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report.
Topics: Dermatologic Agents; Drug Administration Schedule; Facial Dermatoses; Female; Fingers; Glucocorticoi | 1998 |
Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.
Topics: Adolescent; Adult; B-Lymphocytes; Dermatologic Agents; Facial Dermatoses; Female; Humans; Male; Nose | 1999 |